Amgen (AMGN) Total Non-Current Liabilities (2009 - 2026)

Amgen's Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $80.6 billion for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities changed 0.49% year-over-year to $80.6 billion; the TTM figure through Mar 2026 stood at $80.6 billion (changed 0.49% YoY), while the FY2025 annual figure was $79.6 billion, down 4.86% from the prior year.
• Total Non-Current Liabilities was $80.6 billion for Q1 2026 at Amgen, up from $79.6 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $87.9 billion in Q1 2024 to a low of $51.3 billion in Q2 2022.
• Historically, Total Non-Current Liabilities has averaged $76.0 billion across 5 years, with a median of $81.0 billion in 2025.
• The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities soared 62.35% in 2023, then slipped 7.94% in 2025.
• A 5-year view of Total Non-Current Liabilities shows it stood at $61.2 billion in 2022, then soared by 40.94% to $86.2 billion in 2023, then fell by 3.05% to $83.6 billion in 2024, then fell by 4.86% to $79.6 billion in 2025, then gained by 1.26% to $80.6 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $80.6 billion (Q1 2026), $79.6 billion (Q4 2025), and $78.3 billion (Q3 2025), per Business Quant data.